What's breaking now, across thousands of outlets.
The highest dose of retatrutide beat Ozempic on measures of blood sugar and weight loss, but was also associated with higher side effect rates and treatment discontinuations.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
A recurring problem in the spread in Africa is what appears to be lax surveillance efforts.
Carlos Mauricio Gomez, the Salvadoran streamer known as Komanche, died at age 30 in Monterrey, Mexico. News of his death spread on Monday, Oct. 26, after his manager announced it on Instagram, citing the family. Mexican authorities found Komanche at his home and opened an investigation, but they have not confirmed the cause of death. […]
Having obesity in your 20s and 30s could raise your risk for early-onset cancer.
Dr Ato Kwamena Sagoe, a former Ghana Secondary Technical School (GSTS) student who represented the school at the 2005 National Science and Maths Quiz (NSMQ), has died in the United Kingdom following a…
WASHINGTON (AP) — A plan to give Americans easier access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr.
(MedPage Today) -- Overall survival (OS) in heavily pretreated gastroesophageal carcinoma (GEC) doubled in patients who received an investigational antibody-drug conjugate (ADC) targeting claudin (CLDN) 18.2, a randomized trial showed. Patients...
